Lotus Pharmaceuticals Announces Appointment of New Chief Financial Officer
BEIJING, Sept. 9 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People’s Republic of China ("PRC"), announced today that the Company has appointed J...
Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts
BEIJING, Sept. 9 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it has engaged RedChip Companies, Inc., to l...
Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
BEIJING, Aug. 26 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), announced today that it has entered R-Bambuterol(R) Cli...
Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
BEIJING, Aug. 16 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), reported today its financial results for the quarter an...
Lotus Completed R-Bambuterol's Pilot Scale Production for Clinical Trials
BEIJING, Aug. 3 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), announced today that it has completed production of active pha...
Lotus Pharmaceuticals Terminates SEDA
BEIJING, July 22 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People’s Republic of China (the "PRC"), announced today that it has entered into a termination agreem...
Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
BEIJING, July 7 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People’s Republic of China (the "PRC"), today announced it will present at the Global Hu...
Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
Announces 2010 Earnings Guidance BEIJING, May 15 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or "the Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") today reported its financia...
Lotus Pharmaceuticals' Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
BEIJING, April 30 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") today reported that its innovative asthma drug Laevo-Bambuter...
Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA
BEIJING, April 22 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), today reported it will exhibit at the 63rd PHARMCHINA. ...
Lotus Pharmaceuticals' Innovative Drug to Receive SFDA Fast Track Approval
BEIJING, April 21 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its asthma drug Laevo-Bambutero w...
Lotus Pharmaceuticals, Inc. Reports Full Year 2009 Financial Results
BEIJING, April 1 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximate...
Lotus Pharmaceuticals Reports Groundbreaking Ceremony
BEIJING, March 10 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), report...
Lotus Pharmaceuticals Announces New Prescription Drugs
BEIJING, March 3 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported th...
Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project
BEIJING, March 1 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that t...
Lotus Pharmaceuticals Announces Key Changes
BEIJING, Jan. 16 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today rep...
Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
BEIJING, Dec. 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that ef...
Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
BEIJING, Nov. 30 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it...
Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported it will exhibit...
Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results
BEIJING, Nov. 16 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today reported third-quarter ...
